Son La Sugar JSC (HNX:SLS)
Vietnam · Delayed Price · Currency is VND 189,000
-1,000 (-0.53%)
At close: Aug 5, 2025
CTI BioPharma Revenue
Son La Sugar JSC had revenue of 289.57B VND in the quarter ending March 31, 2025, with 19.75% growth. This brings the company's revenue in the last twelve months to 1.34T, down -7.51% year-over-year. In the fiscal year ending June 30, 2024, Son La Sugar JSC had annual revenue of 1.41T, down -17.73%.
Revenue (ttm)
1,340.99B
Revenue Growth
-7.51%
P/S Ratio
1.39
Revenue / Employee
3.04B
Employees
333
Market Cap
1,860.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1,411.69B | -304.24B | -17.73% |
| Jun 30, 2023 | 1,715.94B | 846.96B | 97.47% |
| Jun 30, 2022 | 868.97B | 67.84B | 8.47% |
| Jun 30, 2021 | 801.14B | -247.21B | -23.58% |
| Jul 1, 2020 | 1,048.34B | 170.70B | 19.45% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition